Class IIITerminatedD-0639-2021
Drug recall · June 30, 2021
Phytonadione Tablets recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Phytonadione Tablets, 5 mg, 30-count ablets, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA, NDC 68682-170-30
- Lots / codes
Lot #:19D013P, Exp Date 07/2021; 20D099P, Exp Date 10/2022
- Quantity
- 37,797 bottles
- Company
- Bausch Health Companies, Inc., Bridgewater, NJ
- Distribution
- Nationwide within the United States
- Initiated
- June 8, 2021 · Voluntary: Firm initiated
- Classified
- June 23, 2021
- Reported
- June 30, 2021
- Ended
- February 16, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.